| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11015157 | The American Journal of the Medical Sciences | 2018 | 26 Pages |
Abstract
Adding MRA to a standard medical regimen for NIDCM resulted in beneficial LV remodeling. The maximal beneficial remodeling was achieved with 12-16 months of MRA therapy. These results have implications for the timing of other advanced therapies, such as placing internal cardioverter-defibrillators.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William S. MD, PhD, Susan P. MBBS, MSCI, Shi PhD, Frank E. PhD, Douglas W. MD, Mark A. MD, Douglas B. MD, PhD, Henry MD, Marvin W. MD,